Select your Market
Connecticut
State overview
Connecticut supports our work in advancing therapies for patients with rare tumors, with a focus on differentiated and first‑in‑class treatments.
Our business sector in Connecticut
Healthcare
Our Healthcare operations in Connecticut focus on developing and advancing therapies for rare tumors, including treatments that address significant unmet medical needs. This work supports FDA‑approved medicines as well as a broader portfolio of differentiated, first‑in‑class therapeutic assets.
Site highlights
Stamford
Our Stamford site focuses on rare tumor assets, including a first‑in‑class systemic standard‑of‑care therapy for adults with desmoid tumors and the first and only approved therapy for adult and pediatric patients with Neurofibromatosis type 1 plexiform neurofibromas (NF1‑PN). The site plays an important role in improving patient outcomes and expanding access to innovative therapies worldwide.
Community Engagement
The Curiosity Cube program, which began in 2017, extends our expertise in science and technology to promote science education for 8–13-year-old students.
Experiments are led by local employees, giving students an opportunity to learn from “real life” scientists and ask questions about a future career in STEM!
The Curiosity Cube expands our impact beyond classrooms, reaching more students and families at schools and public events.
88% of students say they are more interested in science after visiting the Curiosity Cube
As a science and technology company, we champion creativity, the joy of discovery and curiosity as well as the courage to push boundaries.